Schedule 13D ownership disclosure

IKENA ONCOLOGY INC

COMMON STOCK · CUSIP: 45175G108

Event date: 2025-07-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 773,754.00 · Class: 6.92%

  • ORBIMED CAPITAL GP VI LLCReported CIK 0001682115

    Shares: 753,063.00 · Class: 6.73%

  • OrbiMed Genesis GP LLCReported CIK 0001808744

    Shares: 20,691.00 · Class: 0.19%

  • ORBIMED CAPITAL LLCReported CIK 0001157524

    Shares: 135,516.00 · Class: 1.21%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000711
Form type
SCHEDULE 13D/A
Filer
ImageneBio, Inc.
CIK
CIK 1835579
Filed
Jul 30, 2025
Reporting period
Jul 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub